QSAR study on some arylsulfonamides as anti-HIV agents

Medicinal Chemistry Research

Volumn 16, Issue 7-9, 2007, Pages 342-351

  Ravichandran, Veerasamy ^a   Jain, Prateek Kumar ^a   Mourya, Vishnu Kant ^b   Agrawal, Ram Kishore ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b GOVERNMENT COLLEGE OF PHARMACY   (India)

Author keywords

Anti HIV agents; Arylsulfonamides; HIV 1 protease inhibitors; QSAR

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR; SULFONAMIDE;

ANTIVIRAL ACTIVITY; ARTICLE; EXTERNAL VALIDITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INTERNAL VALIDITY; MULTIPLE LINEAR REGRESSION ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL SIGNIFICANCE; THERMODYNAMICS;

EID: 51749092464     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-007-9034-7     Document Type: Article

References (22)

1. F Barre-Sinoussi JC Chermann F Rey MT Nugeyre S Chamaret J Gruest C Dauguet C Axler-Blin F Vezinet-Brun C Rouzioux W Rozenbaum L Montagnier 1983 Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 220 868 871
2. RA Chrusciel JW Strohbach 2004 Non-peptidic HIV protease inhibitors Curr Top Med Chem 4 1097 1114
3. RC Gallo SZ Salahuddin M Popovic GM Shearer M Kaplan BF Haynes TJ Palker R Redfield J Oleske B Safai 1984 Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS Science 224 500 503
4. R Garg SP Gupta H Gao SB Mekapati AK Debnath C Hansch 1999 Comparative quantitative structure activity relationship studies on anti-HIV drugs Chem Rev 99 3525 3602
5. A Golbraikh A Tropsha 2002 Beware of q2! J Mol Graph Model 20 269 276
6. HG Gottlinger JG Sodroski WA Haseltine 1989 Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 Proc Natl Acad Sci.USA 86 5781 5785
7. SP Gupta MS Babu R Garg S Sowmya 1998 Quantitative structure-activity relationship studies on cyclic urea-based HIV protease inhibitors J Enzyme Inhib 13 399 407
8. P Gayathri V Pande R Sivakumar SP Gupta 2001 A quantitative structure-activity relationship study on some HIV-1 protease inhibitors using molecular connectivity index Bioorg Med Chem 9 3059 3063
9. Hanch C, Leo A (1995) Exploring QSAR, Fundamentals and Applications in Chemistry and Biology; American Chemical Society: Washington, DC, 90-100
10. LE Henderson RC Sowder TD Copeland S Oroszlan RE Benveniste 1990 Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions J Med Primatol 19 411 419
11. NE Kohl NA Emini WA Schleif LJ Davis JC Heimbach RAF Dixon EM Scolnick IS.Sigal 1988 Active human immunodeficiency virus protease is required for viral infectivity Proc Natl Acad Sci USA 85 4686 4690
12. Kubinyi H (1993) In: Methods and Principles in Medicinal Chemistry, Mannhold R, Krogsgaard-Larsen R, Timmerman H (Eds) VCH: Weincheim, 1:91-95
13. A Kurup SB Mekapati R Garg C Hansch 2003 HIV-1 protease inhibitors: a comparative QSAR analysis Curr Med Chem 10 1679 1688
14. TJ McQuade AG Tomasselli L Liu V Karacostas B Moss 1990 A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation Science 247 454 456
15. JF Miller M Brieger ES Furfine RJ Hazen I Kaldor D Reynolds RG Sherrill A Spaltenstein 2005 Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles Bioorg Med Chem Lett 15 3496 3500
16. C Peng BK Ho TW Chang NT Chang 1989 Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity J Virol 63 2550 2556
17. V Ravichandran RK Agrawal 2007 Predicting anti-HIV activity of PETT derivatives: CoMFA approach Bioorg Med Chem Lett 17 2197 2202
18. KK Sahu V Ravichandran VK Mourya RK Agrawal 2007 QSAR analysis of caffeoyl naphthalene sulphonamide derivatives as HIV-1 integrase inhibitors Med Chem Res 15 418 430
19. S Seelmier H Schmidt V Turk VDK Helm 1988 Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A Proc Natl Acad Sci USA 85 6612 6616
20. VM Vogt 1996 Proteolytic processing and particle maturation Curr Top Microbiol Immunol 214 95 131
21. M Wagener J Sadowski J Gasteiger 1995 Autocorrelation of molecular surface properties for modeling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks J Am Chem Soc 117 7769 1775
22. Wold S, Eriksson L (1995) In: Chemometrics Methods in Molecular Design. Waterbeemed H (ed) VCH: Weincheim, 309-318